Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 20 | 10 | 0 | 120 |
| Receivables | 0 | 5 | 8 | 5 | 10 |
| Other current assets | 10 | 15 | 2 | 5 | 20 |
| TOTAL | $30 | $40 | $20 | $10 | $150 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 20 | 20 |
| Other Non-Current Assets | 5 | 25 | 25 | 5 | 5 |
| TOTAL | $5 | $25 | $25 | $25 | $25 |
| Total Assets | $70 | $100 | $90 | $80 | $230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 210 | 140 | 160 | 120 | 90 |
| Accrued Expenses | 40 | 30 | 10 | 20 | 10 |
| TOTAL | $960 | $870 | $880 | $910 | $810 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,840 | 5,840 | 5,840 | 5,840 | 5,840 |
| Other Non-Current Liabilities | 9,680 | 9,490 | 9,300 | 8,890 | 8,710 |
| TOTAL | $15,520 | $15,330 | $15,140 | $14,730 | $14,550 |
| Total Liabilities | $16,490 | $16,210 | $16,030 | $15,660 | $15,370 |
| Shareholders' Equity | |||||
| Common Shares | 1,090 | 1,090 | 1,080 | 1,080 | 1,070 |
| Retained earnings | -43,170 | -42,860 | -42,640 | -42,480 | -42,010 |
| Other shareholders' equity | 10 | 0 | 10 | 360 | 360 |
| TOTAL | $-16,410 | $-16,110 | $-15,930 | $-15,570 | $-15,140 |
| Total Liabilities And Equity | $80 | $100 | $100 | $90 | $230 |